These researchers would be in Africa fighting ebola—but Trump cut their funding

A critical network of infectious disease research centers operating across multiple continents has found itself sidelined from frontline pandemic response efforts precisely when its expertise is most urgently needed. The Centers for Research in Emerging Infectious Diseases, commonly referred to as CREID, established through the National Institutes of Health in 2020, has been effectively shuttered following a decision by the Trump administration to terminate its funding. This action came despite an active and expanding Ebola outbreak currently spreading through the Democratic Republic of the Congo's Ituri Province, a region where such surveillance and research capacity could prove invaluable to public health authorities. The network, which operated ten strategically positioned research sites across the globe with particular concentration in Central and East Africa, specialized in identifying and studying viruses that jump from animal populations to humans—precisely the epidemiological pathway that produces outbreaks like the current Ebola crisis. The termination decision, officially communicated through a stop-work order issued in June of the previous year, fundamentally disrupted research infrastructure that had been painstakingly developed to detect and respond to emerging pathogenic threats before they escalate into major public health emergencies. Understanding why such specialized research infrastructure proved politically vulnerable requires examining the broader context in which disease surveillance and pandemic preparedness has become entangled with partisan disputes and misinformation. The Trump administration's decision to withdraw support from CREID research represented a significant departure from decades of bipartisan consensus that maintaining robust capacity for detecting and studying novel pathogens served essential national security interests.

The network's termination occurred against a backdrop of intensified skepticism toward research institutions and international health cooperation, fueled partly by conspiracy theories concerning the origins of COVID-19 and partly by a broader skepticism toward what the administration characterized as wasteful government spending on academic research. This ideological reorientation threatened to reverse substantial investments made by previous administrations in building the institutional capacity to identify zoonotic disease threats before they become widespread epidemics. The consequences extend beyond the immediate research community affected; the decision raises profound questions about how political considerations increasingly influence decisions regarding public health infrastructure and pandemic preparedness, factors that transcend partisan affiliation and directly impact population health outcomes across multiple nations. The CREID network represented a sophisticated approach to infectious disease surveillance grounded in scientific evidence about how most emerging pathogens originate. The ten research sites were deliberately positioned in regions where ecological conditions create high probability of human-animal contact and viral transmission, including areas of Central Africa where Ebola regularly circulates in wildlife populations. Researchers working within the network conducted sophisticated epidemiological and laboratory investigations designed to understand transmission pathways, identify early warning signs of outbreaks, and develop rapid response protocols. The network received approximately eighty-two million dollars in federal funding allocated across five years, representing a modest investment relative to the scale of resources typically mobilized after a major outbreak has already begun.

When the funding came up for renewal in 2025, administrators at CREID submitted renewal applications expecting the standard peer review process, only to receive notification that the network no longer aligned with agency priorities. The official justification, that the research had been deemed unsafe for Americans and represented questionable use of public money, struck many infectious disease experts as inconsistent with the network's actual operations and scientific rationale, suggesting that bureaucratic and political considerations had superseded scientific merit in the decision-making process. The sudden defunding of CREID has generated substantial concern within the scientific community and among public health professionals, with numerous experts articulating alarm about the implications for future pandemic preparedness. Multiple infectious disease researchers emphasized that the network represented the type of forward-looking infrastructure that enables early detection of threats before they metastasize into major epidemics requiring vastly greater resources to manage. These specialists noted that the approximately eighty-two million dollar investment in proactive surveillance appeared trivial compared to the billions ultimately required to respond to major outbreaks. Public health officials in African nations where CREID sites operated expressed concern about the loss of technical capacity and research infrastructure that had begun generating valuable epidemiological data about regional disease ecology. The termination decision has also prompted broader questions within international health circles about the reliability of the United States as a long-term partner in global disease surveillance efforts, potentially encouraging other nations to reduce their own dependence on American research institutions and collaborative frameworks.

Some observers noted that the timing of the defunding, occurring amid an active Ebola outbreak, underscored the practical consequences of allowing political considerations to override epidemiological reasoning in pandemic preparedness policy. The defunding of CREID illuminates deeper patterns about how scientific institutions increasingly find themselves vulnerable to political pressures, particularly when their work touches on contentious policy areas or requires acknowledging uncertainties that some policymakers find uncomfortable to acknowledge. The network's research into how viruses emerge from wildlife populations and jump to humans proved especially susceptible to politicization, as certain actors promoted unfounded narratives about laboratory origins of pathogens. Rather than engaging substantively with the scientific evidence supporting the network's work, critics invoked vague accusations about safety and fiscal responsibility without detailed technical justification. This approach reflects a troubling trend in which scientific institutions defending themselves against ideologically motivated attacks find themselves at disadvantage, since scientific institutions typically operate through transparent processes involving peer review and published findings, while political attacks often rely on innuendo and unsubstantiated claims. The CREID defunding thus represents not merely a budget decision but a symptomatic case of how institutional capacity for dealing with known public health threats has become entangled with partisan conflicts that lack substantive grounding in epidemiological evidence or scientific expertise. The path forward for pandemic preparedness and disease surveillance capacity now depends on several critical developments that warrant close monitoring.

First, observers should track whether any effort emerges among Congress members to restore funding for CREID or establish alternative mechanisms for sustaining the research infrastructure and institutional knowledge that the network had cultivated across its ten sites. Second, international attention should focus on whether other nations develop parallel surveillance networks that operate independently of American institutions, which would fragment the global effort to detect emerging pathogens and could diminish overall effectiveness of international disease monitoring. The ongoing Ebola outbreak in the Democratic Republic of the Congo will test whether disease response capacity has genuinely been impaired by CREID's closure or whether existing alternative mechanisms prove sufficient to address the crisis. Additionally, the coming months will reveal whether infectious disease researchers successfully make the case to policymakers that pandemic preparedness represents fundamentally different category of investment than discretionary spending, requiring sustained funding based on epidemiological assessment rather than political calculation. The stakes of these developments extend far beyond academic research budgets; they ultimately determine how well prepared society remains for the next major disease threat, whenever and wherever it emerges.